Metal-Assisted Microwave Decrystallization of Uric Acid
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for gout, such as anti-inflammatory and urate-lowering drugs, are limited by side effects and the need for long-term adherence, and there is a need for new methodologies that minimize risks of bodily complications.
Innovation Solution
The Metal-Assisted and Microwave-Accelerated De-crystallization (MAMAD) technology uses sterile metal colloids, preferably gold colloids, excited by microwave energy to break down uric acid crystals in human tissues and joints, creating a thermal gradient that increases the kinetic energy of metal nanoparticles to collide with and fracture uric acid crystals.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If anti-inflammatory drugs (NSAIDs and glucocorticoids) are used to treat gout, then the symptoms of gout are relieved, but side effects such as gastrointestinal ulceration, renal dysfunction, and increased infection risk occur
Solution Approach 1:
The patent replaces chemical drug treatment with a physical treatment method using microwave radiation and metal colloids to mechanically break down uric acid crystals through kinetic energy transfer, eliminating the need for pharmaceutical interventions that cause harmful side effects
Solution Approach 2:
The patent introduces metal colloids as intermediary agents that absorb microwave energy and convert it to kinetic energy, serving as a mediator between the microwave radiation and uric acid crystals to achieve crystal breakdown without direct thermal damage to surrounding tissues
2Reliability
If urate-lowering drugs are used to treat gout, then serum urate concentration is reduced, but the need for life-long adherence and potential for renal injury and life-threatening allergic reactions increase
Solution Approach 1:
The patent replaces long-term chemical medication with a single or limited-session physical treatment using microwave-accelerated metal colloid therapy to directly decompose existing uric acid crystals, eliminating the need for lifelong drug adherence
Solution Approach 2:
The patent performs preliminary breakdown of uric acid crystals through microwave-mediated metal colloid action before the crystals can cause further damage or require ongoing management, addressing the root cause rather than managing symptoms chronically
3Productivity
If microwave energy is applied to heat tissues, then temperature increases to accelerate processes, but uncontrolled heating can cause thermal damage to surrounding tissues
Solution Approach 1:
The patent applies heating locally and selectively to uric acid crystals through metal colloid-mediated microwave absorption, creating localized thermal effects at the crystal level while maintaining relatively lower temperatures in surrounding healthy tissues, thus achieving high decrystallization rates without widespread thermal damage
Solution Approach 2:
The patent uses metal colloids as intermediary agents that selectively absorb microwave energy and convert it to kinetic energy through localized heating, mediating between the microwave radiation and uric acid crystals to achieve precise thermal control that breaks down crystals without damaging surrounding tissues
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method demonstrates a significant reduction in uric acid crystals, up to 60%, with gold colloids and microwave heating, reducing the need for pharmaceutical drugs and improving quality of life for gout patients by effectively de-crystallizing uric acid deposits.
Implementation Method 1
The absorption/reflection of electromagnetic energy and subsequent conversion to additional kinetic energy by metal nanoparticles exposed to microwave irradiation
Implementation Method 2
where a microwave-induced temperature gradient exists. Metal colloids in solution convert the microwave energy to kinetic energy to move about the uric acid solution for the de-crystallization process
Data Source
AI summary
In this study, we demonstrated a unique application of our Metal-Assisted and Microwave-Accelerated Decrystallization (MAMAD) technique for the de-crystallization of uric acid crystals, which causes gout in humans when monosodium urate crystals accumulate in the synovial fluid found in the joints of bones. Given the shortcomings of the existing treatments for gout, we investigated whether the MAMAD technique can offer an alternative solution to the treatment of gout. Our technique is based on the use of metal nanoparticles (i.e., gold colloids) with low microwave heating to accelerate the de-crystallization process. In this regard, we employed a two-step process; (i) crystallization of uric acid on glass slides, which act as a solid platform to mimic a bone, (ii) de-crystallization of uric acid crystals on glass slides with the addition of gold colloids and low power microwave heating, which act as “nano-bullets” when microwave heated in a solution. We observed that the size and number of the uric acid crystals were reduced by >60% within 10 minutes of low power microwave heating. In addition, the use of gold colloids without microwave heating (i.e. control experiment) did not result in the de-crystallization of the uric acid crystals, which proves the utility of our MAMAD technique in the de-crystallization of uric acid.